Valneva
General Information
Identification Code: 116284040570-75
Website: [object Object]
Entity Form: SE
Registration Category: Companies & groups
Registration Date: 12/4/2020
Last Update: 1/17/2024
EP Accredited Number: 0
Mission & Interests
Goals: Valneva is a specialty vaccine company focused on prevention against diseases with major unmet needs. The Company has several vaccines in development including vaccines against Lyme diseaseand chikungunya (the latter having received approval by US FDA in 2023). Valneva’s portfolio includes two commercial vaccines for travelers: IXIARO®/JESPECT® indicated for the prevention of Japanese encephalitis and DUKORAL® indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by ETEC.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Humanitarian aid and civil protection
- International co-operation and development
- Public health
- Research and innovation
Levels of Interest:
- sub-national
- european
- national
- global
Activities
Main EU Legislative Proposals: Given Valneva’s experience in emerging diseases, the company’s business is actually or potentially affected by most of the policies related to Public Health, Research and Innovation. More specifically: Horizon Europe (Horizon 2020), EU4Health, Cross Border Health Threats Regulation, Pharmaceutical Strategy, New Industrial Strategy for Europe, Union Civil Protection Mechanism, HERA, EU FAB, European Critical Medicines Alliance.
Communication Activities: Starting shot for vaccines. Early lessons from the ups and downs of COVID-19 immunisation roll-out(s) - in cooperation with European Health Forum Gastein (2021)
"Outbreak Diseases: a sudden risk, a constant threat” - Event in the European Parliament to address preparedness for outbreak diseases.
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: 6 rue Alain Bombard
Post Code: 44800
City: Saint-Herblain
Country: FRANCE
Phone: [object Object]
EU Office
Address: Campus Vienna Biocenter 3
Post Code: 1030
City: Wien
Country: AUSTRIA
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Membership Information
Members10 Percent: 0
Members25 Percent: 0
Members50 Percent: 0
Members75 Percent: 0
Members: 1
Members F T E: 1
Info Members: Valneva created in 2023 a Government Affairs function, albeit with only one person in charge for global activities and also acting for Europe. This position is therefore supported on EU policy affairs by several members of the team are overseeing the activities on ad hoc basis.
Structure
Structure Type: Structure
Is Member Of: n/a
Organisation Members: Vaccines Europe
France Biotech
Pharmig - Verband der pharmazeutischen Industrie Österreichs
ÖVIH - Österreichischer Verband der Impfstoffhersteller
WKÖ - Austrian Federal Economic Chamber
Industriellenvereinigung (Vereinigung der Österreichischen Industrie)
Signatary of UN Global Compact
LIF - Läkemedelsindustriföreningens
LEEM - Les Entreprises du Médicament
ABPI UK - The Association of the British Pharmaceutical Industry
Royal Society of Biology (UK)
Biotechnology Innovation Organization (BIO, USA)
Adult Vaccine Access Coalition (AVAC, USA)
Medical Countermeasures Coalition (MC2, USA)